Study of Characteristics and Types of Heart Failure With Preserved Ejection Fraction HFpEF at Manchester University NHS Foundation Trust
Led by Manchester University NHS Foundation Trust · Updated on 2025-10-01
1250
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Heart failure with preserved ejection fraction HFpEF is a type of heart failure where the heart does not pump blood properly, causing symptoms like breathlessness, tiredness, and swollen feet or ankles. The reasons why people develop HFpEF are not well understood, and current treatment options are limited. This observational study called TRAITS-HFpEF aims to better understand the causes of HFpEF, identify new tests and treatments, and gather information about the life expectancy of people living with this condition by collecting routine data from patients attending a specialized outpatient HFpEF clinic.
The study involves recruiting approximately 1,250 patients who visit the HFpEF clinic at Manchester University NHS Foundation Trust over a 5-year period. With patient consent, a blood sample of about 10mL may be taken for biobanking to study potential new biomarkers, including plasma and DNA. All clinical information will be collected and documented at the time of recruitment to help identify different HFpEF patient types and their outcomes.
Participants will be observed over approximately 7.5 years to monitor outcomes such as overall mortality and hospitalizations due to heart failure. Researchers will regularly collect clinical data and track patient health status during this time. The study will help characterize HFpEF patient groups and inform future research and specialist care strategies. Participation involves routine clinic visits and optional blood sample collection, with no study treatments administered.
CONDITIONS
Brief Title
Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)
Research Team
F
Fardad Soltani, MBChB, MRCP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients attending the HFpEF clinic at Manchester University NHS Foundation Trust
You will not qualify if you...
Age under 18 years
Imprisonment
Inability to provide full written or verbal informed consent in English
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Surveillance
Duration - Up to 7.5 years
Participants are observed over time to assess clinical variables and outcomes related to heart failure with preserved ejection fraction (HFpEF).
Participants attend a specialist HFpEF clinic for assessments and optional blood sample collection at recruitment.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Phase 1 Study to Evaluate Safety and Biomarkers of VS-041 in Adults 50 and Older with Heart Failure with Preserved Ejection Fraction HFpEF
A Phase II Study to Test the Safety and Effectiveness of IBI362 in Adults With Heart Failure and Obesity
AI-Enhanced Continuous Remote Monitoring Using Wearable Devices to Improve Outcomes in Adults with Chronic Heart Failure
Study of Pregnancy History and Circulating Biomarkers in Women Aged 60-74 With Heart Failure and Preserved Ejection Fraction
Study of Characteristics and Types of Heart Failure With Preserved Ejection Fraction HFpEF at Manchester University NHS Foundation Trust
Screening Study for Heart Failure With Preserved Ejection Fraction in Adults Aged 50 to 89 in the Capital Region of Denmark
Evaluating the Effect of Coronary Artery Stents on Quality of Life in Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease
Study to Find Hidden Heart Failure in At-Risk Adults Aged 40 to 69 in German Cities Using Mobile MRI Screening
Study of Personalized Dual Chamber Cardiac Pacing for Treating Heart Failure With Preserved Ejection Fraction in Adults 40 and Older
Assessment of Exercise Capacity in Heart Failure Patients with Preserved Ejection Fraction
Based on Coronary Microvascular Function and Body Composition
Heart Failure With Preserved Ejection Fraction (HFpEF)
Actively Recruiting
1 location
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker...